WILLIS TOWERS WATSON PLC·4

Jul 17, 4:06 PM ET

Gebauer Julie Jarecke 4

4 · WILLIS TOWERS WATSON PLC · Filed Jul 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Willis Towers Watson (WTW) Pres. Julie Gebauer Receives RSU Award

What Happened
Julie J. Gebauer, President — Health, Wealth & Career at Willis Towers Watson (WTW), was awarded a total of 112.726 restricted share units (RSUs) on 2026-07-15. The filing shows three award lines: 11.669 RSUs (acquired at $0.00), 82.226 RSUs (derivative/dividend-equivalent, $0.00) and 18.831 RSUs (derivative/dividend-equivalent, $0.00). These are awards (not purchases or sales) and carry no immediate cash price; they represent equity compensation that will convert to ordinary WTW shares per plan terms.

Key Details

  • Transaction date: 2026-07-15; Filing date: 2026-07-17 (appears timely under Form 4 rules).
  • Award amounts: 11.669 RSUs; 82.226 RSUs (derivative); 18.831 RSUs (derivative) — total 112.726 RSUs. Price per unit reported: $0.00.
  • Shares owned after transaction: not disclosed in the filing.
  • Notable footnotes:
    • Dividend-equivalent rights accrued on previously reported RSUs and vest on same schedule as underlying awards (F1).
    • Certain RSUs settle 1:1 for ordinary shares six months after the reporting person’s termination (F2, F4).
    • Some RSUs reflect contributions/matching under the company’s Non‑Qualified Deferred Savings and Stable Value Excess plans (F3, F5).
  • Transaction type: Award/Grant (code A) — not an open-market trade or option exercise.

Context
These entries are equity compensation and derivative/dividend-equivalent rights that will convert to ordinary WTW shares only when plan/vesting conditions are met (including post-termination settlement rules noted in the footnotes). Awards and dividend-equivalent RSUs are routine components of executive pay and do not by themselves indicate an intent to buy or sell stock in the open market.

Insider Transaction Report

Form 4
Period: 2026-07-15
Gebauer Julie Jarecke
Pres.-Health, Wealth & Career
Transactions
  • Award

    Ordinary Shares, nominal value $0.000304635 per share

    [F1]
    2026-07-15+11.66978,033.925 total
  • Award

    Restricted Share Unit

    [F2][F3]
    2026-07-15+82.22624,568.649 total
    Ordinary Shares, nominal value $0.000304635 per share (82.226 underlying)
  • Award

    Restricted Share Unit

    [F4][F5]
    2026-07-15+18.8315,613.711 total
    Ordinary Shares, nominal value $0.000304635 per share (18.831 underlying)
Holdings
  • Ordinary Shares, nominal value $0.000304635 per share

    (indirect: By Trust)
    534
  • Ordinary Shares, nominal value $0.000304635 per share

    (indirect: By Trust)
    534
Footnotes (5)
  • [F1]The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit awards and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.
  • [F2]Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.
  • [F3]Represents dividends acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.
  • [F4]Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.
  • [F5]Represents dividends acquired pursuant to the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees (the "Excess Plan"), including the participant's deferral election under the Excess Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Excess Plan.
Signature
/s/ Julie J. Gebauer by Gary Pang, Attorney-in-Fact (power of attorney previously filed)|2026-07-17

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT